Veracyte reported $0.53 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2024Q4 Dec/2025 0.53 0.39 0.36 Feb/25 2026
FY2025Q3 Sep/2025 0.51 0.32 0.33 Nov/04 2025
FY2025Q2 Jun/2025 0.44 0.12 0.07 Aug/06 2025
FY2025Q1 Mar/2025 0.31 0.02 -0.02 May/07 2025
FY2023Q4 Dec/2024 0.36 0.10 -0.39 Feb/24 2025




Eps Change Date
Agenus USD -1.03 1.01 Mar/2025
Agilent USD 1.67 0.37 Sep/2025
Anika Therapeutics USD -0.34 1.16 Mar/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Bruker USD 0.59 0.14 Dec/2025
Exact Sciences USD -0.45 0.69 Dec/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Illumina USD 1.35 0.01 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Laboratory Of America USD 4.07 0.11 Dec/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
Myriad Genetics USD 0.04 0.01 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Siemens EUR 2.58 0.5 Dec/2025
Sonic Healthcare AUD 0.53 0.04 Dec/2025
Thermo Fisher Scientific USD 6.57 0.78 Dec/2025
Veracyte USD 0.53 0.02 Dec/2025
Waters USD 4.53 1.13 Dec/2025